- Home
- RUSHA vs AKRO Comparison
RUSHA vs AKRO Comparison
Compare RUSHA & AKRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RUSHA
- AKRO
- Stock Information
- Founded
- RUSHA 1965
- AKRO 2017
- Country
- RUSHA United States
- AKRO United States
- Employees
- RUSHA N/A
- AKRO N/A
- Industry
- RUSHA Retail-Auto Dealers and Gas Stations
- AKRO Biotechnology: Pharmaceutical Preparations
- Sector
- RUSHA Consumer Discretionary
- AKRO Health Care
- Exchange
- RUSHA Nasdaq
- AKRO Nasdaq
- Market Cap
- RUSHA 4.5B
- AKRO 3.9B
- IPO Year
- RUSHA 1996
- AKRO 2019
- Fundamental
- Price
- RUSHA $56.37
- AKRO $49.38
- Analyst Decision
- RUSHA Buy
- AKRO Strong Buy
- Analyst Count
- RUSHA 1
- AKRO 7
- Target Price
- RUSHA $61.00
- AKRO $81.57
- AVG Volume (30 Days)
- RUSHA 398.7K
- AKRO 1.1M
- Earning Date
- RUSHA 07-30-2025
- AKRO 08-08-2025
- Dividend Yield
- RUSHA 1.35%
- AKRO N/A
- EPS Growth
- RUSHA N/A
- AKRO N/A
- EPS
- RUSHA 3.51
- AKRO N/A
- Revenue
- RUSHA $7,687,256,000.00
- AKRO N/A
- Revenue This Year
- RUSHA N/A
- AKRO N/A
- Revenue Next Year
- RUSHA $9.87
- AKRO N/A
- P/E Ratio
- RUSHA $16.06
- AKRO N/A
- Revenue Growth
- RUSHA N/A
- AKRO N/A
- 52 Week Low
- RUSHA $46.30
- AKRO $21.34
- 52 Week High
- RUSHA $65.43
- AKRO $58.40
- Technical
- Relative Strength Index (RSI)
- RUSHA 56.32
- AKRO 47.31
- Support Level
- RUSHA $54.49
- AKRO $47.10
- Resistance Level
- RUSHA $59.16
- AKRO $50.19
- Average True Range (ATR)
- RUSHA 1.74
- AKRO 2.36
- MACD
- RUSHA 0.19
- AKRO 0.02
- Stochastic Oscillator
- RUSHA 58.91
- AKRO 51.14
About RUSHA Rush Enterprises Inc. Cl A
Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States and Ontario, Canada commercial vehicle markets and related aftermarkets.
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.